2026-07-25 02:55:42
Latest Post
TANFAC Industries Reports Q1 FY27 Net Profit of ₹16.85 Crore; Operational Revenue Up 6.3% YoY to ₹187.18 Crore
New India Assurance Reports Q1 FY27 Net Loss of ₹243.94 Crore; Gross Written Premium Rises 2.9% YoY to ₹13,835 Crore
NTPC Consolidated Q1 FY27 Net Profit Rises 12.9% YoY to ₹6,896 Crore; Operational Revenue Up 7.8% at ₹50,741 Crore
Neogen Chemicals Reports Q1 FY27 Net Profit Surge of 66.8% YoY to ₹17.11 Crore; Operational Revenue Up 34% at ₹250.29 Crore
Arihant Capital Markets Reports Q1 FY27 Net Profit of ₹21.49 Crore, Up 69.2% YoY; Operational Revenue Jumps 53.5%
Stock Report
Sharon Bio Medicine to discuss about project in Uttaranchal
Posted On : 2007-01-16 12:13:12( TIMEZONE : IST )
Sharon Bio Medicine Ltd has announced that a meeting of the Board of Directors of the Company will be held on January 23, 2007, inter alia, to take on record the Unaudited Financial Results for the 2nd Quarter ended on December 31, 2006 and to discuss the progress of the ongoing project at Uttaranchal.
